Bayer Intellectual Property Gmbh

Dow Agrosciences LLC

Bayer Schering Pharma Ag

4Sc Ag

Bayer Pharma Aktiengesellschaft

Hemant Joshi

Thomas Beckers

Astrid Zimmermann

Volker Gekeler

Swen Hölder

Armin Zülch

Thomas Maier

Matthias Vennemann

Sarvesh S Patel

William C Lo

Gerald Bryan Watson

James Edward Hunter

Thomas Bär

Gerrit Beneke

Yogesh Munot

Umesh Bhise

Sunil Chavan

Sachin Shivatare

Vikas Gore

Beth Lorsbach

Thomas Clarence Sparks

David Anthony Demeter

Michael R Loso

Akshay Patny

Joshodeep Boruwa

Gary David Gustafson

John M Herbert

Paul Renee LePlae, Jr

Pravin S Iyer

Debra L Camper

Thomas Baer

William Kirkland Brewster

Dan Pernich

Thomas J Barton

Petra Gimmnich

Raghuram Tangirala

Xin Gao

Uday Joshi

Rambabu Gundla

Kamlesh Padiya

Mahindra Makhija

Dipak Harel

Kamlesh J Padiya

Adiraj Mandaleswaran

Ramadevi Sanam

Sarvesh A Patel

Yogesh S Munot

Sachin S Shivatare

This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula ('Formula One'). 

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

This document discloses molecules having the following formula ('Formula One'): and processes associated therewith.

Pesticidal compositions and processes related thereto

Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.

Fused bicyclic imidazoles

Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the pyrimidine to which it is fused, R4, R5, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.

Fused bicyclic pyrimidines

The compounds of formula (I), wherein ring D and ring E together form a fused ring system selected from formula (II), (III), (IV), (V), (VI), (VII), and the salts of these compounds are novel, effective inhibitors of histone deacetylases. 

Tetrahydro-fused pyridines as histone deacetylase inhibitors

Growing community of inventors

Navi Mumbai, India

Hemant Joshi